From patterns to patients: Advances in clinical machine learning for cancer diagnosis, prognosis, and treatment

K Swanson, E Wu, A Zhang, AA Alizadeh, J Zou - Cell, 2023 - cell.com
Machine learning (ML) is increasingly used in clinical oncology to diagnose cancers, predict
patient outcomes, and inform treatment planning. Here, we review recent applications of ML …

Self-supervised learning for medical image classification: a systematic review and implementation guidelines

SC Huang, A Pareek, M Jensen, MP Lungren… - NPJ Digital …, 2023 - nature.com
Advancements in deep learning and computer vision provide promising solutions for
medical image analysis, potentially improving healthcare and patient outcomes. However …

Artificial intelligence predictive model for hormone therapy use in prostate cancer

DE Spratt, S Tang, Y Sun, HC Huang, E Chen… - NEJM …, 2023 - evidence.nejm.org
Background Androgen deprivation therapy (ADT) with radiotherapy can benefit patients with
localized prostate cancer. However, ADT can negatively impact quality of life, and there …

Artificial intelligence applications in prostate cancer

A Baydoun, AY Jia, NG Zaorsky, R Kashani… - Prostate cancer and …, 2024 - nature.com
Artificial intelligence (AI) applications have enabled remarkable advancements in healthcare
delivery. These AI tools are often aimed to improve accuracy and efficiency of histopathology …

Patients' trust in artificial intelligence–based decision-making for localized prostate cancer: results from a prospective trial

S Rodler, R Kopliku, D Ulrich, A Kaltenhauser… - European Urology …, 2024 - Elsevier
Background Artificial intelligence (AI) has the potential to enhance diagnostic accuracy and
improve treatment outcomes. However, AI integration into clinical workflows and patient …

Prediction of recurrence risk in endometrial cancer with multimodal deep learning

S Volinsky-Fremond, N Horeweg, S Andani… - Nature Medicine, 2024 - nature.com
Predicting distant recurrence of endometrial cancer (EC) is crucial for personalized adjuvant
treatment. The current gold standard of combined pathological and molecular profiling is …

Application of digital pathology‐based advanced analytics of tumour microenvironment organisation to predict prognosis and therapeutic response

X Fu, E Sahai, A Wilkins - The Journal of Pathology, 2023 - Wiley Online Library
In recent years, the application of advanced analytics, especially artificial intelligence (AI), to
digital H&E images, and other histological image types, has begun to radically change how …

NCCN Guidelines® Insights: Prostate Cancer, Version 3.2024: Featured Updates to the NCCN Guidelines

EM Schaeffer, S Srinivas, N Adra, Y An… - Journal of the National …, 2024 - jnccn.org
The NCCN Guidelines for Prostate Cancer include recommendations for staging and risk
assessment after a prostate cancer diagnosis and for the care of patients with localized …

Deep learning methodologies applied to digital pathology in prostate cancer: a systematic review

N Rabilloud, P Allaume, O Acosta, R De Crevoisier… - Diagnostics, 2023 - mdpi.com
Deep learning (DL), often called artificial intelligence (AI), has been increasingly used in
Pathology thanks to the use of scanners to digitize slides which allow us to visualize them on …

Artificial Intelligence in Oncology: Current Landscape, Challenges, and Future Directions

W Lotter, MJ Hassett, N Schultz, KL Kehl, EM Van Allen… - Cancer Discovery, 2024 - AACR
Artificial intelligence (AI) in oncology is advancing beyond algorithm development to
integration into clinical practice. This review describes the current state of the field, with a …